Intuitive Surgical, Inc. (ISRG)
Robotic Surgery Titan Intuitive Surgical Slips On Conservative, But Expected, Guidance
Intuitive Surgical stock skidded late Thursday despite beating profit expectations following a strong sales preannouncement that sent shares on a sprint. The post Robotic Surgery Titan Intuitive Surgical Slips On Conservative, But Expected, Guidance appeared first on Investor's Business Daily.
Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring?
Shares of robotic surgery pioneer Intuitive Surgical (ISRG -0.29%) have been soaring lately. A preliminary look at sales results from the fourth quarter of 2024 suggests its business is on the right track.
Wall Street Eyes Intuitive Surgical Q4 Earnings As Stock Hits New Heights
Intuitive Surgical, Inc. ISRG is announcing its fourth-quarter earnings on Thursday. Wall Street expects $1.79 in EPS and $2.25 billion in revenues as the company reports after market hours.
Earnings Preview: What To Expect From Intuitive Surgical
Intuitive Surgical scheduled to report earnings after Thursday's close. The stock hit a record high of $614.72/share on Wednesday.
ISRG Likely to Beat Q4 Expectations: How to Play the Stock?
Intuitive Surgical's fourth-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Is It Too Late to Invest in Intuitive Surgical Stock After Its Nearly 60% Surge?
Intuitive Surgical (ISRG 1.94%) is a healthcare company that makes robotic-assisted surgical devices. Its da Vinci surgical systems can assist surgeons make minimally invasive and precise procedures, which can help save lives and improve outcomes for patients.
Intuitive Surgical Leads the Pack in Robotic Surgery Innovation
Leading robotic surgery systems developer Intuitive Surgical Inc. NASDAQ: ISRG kicked off the new year by issuing upside guidance for its fourth quarter of 2024. Its da Vinci Surgical System has had a first-mover advantage ever since it launched in 2000, becoming the first commercial robotic surgical platform approved by the FDA.
Intuitive Surgical: Second Half 2025 Guidance Is Critical To Maintaining Current Euphoria
Intuitive Surgical's share price surged after the company reported 25% YoY revenue growth in the fourth quarter. Despite macro headwinds, robust procedure volumes, international expansion and new product rollouts continue to support growth. While investors probably should look through the current growth surge, particularly given Intuitive's extreme valuation, near term earnings beats could continue to drive the stock higher.
3 Unstoppable Stocks to Buy in 2025
You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong underlying business prospects that they're practically unstoppable.
Exploring Analyst Estimates for Intuitive Surgical (ISRG) Q4 Earnings, Beyond Revenue and EPS
Evaluate the expected performance of Intuitive Surgical (ISRG) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Watch These Intuitive Surgical Price Levels as Stock Hits Another Record High
Intuitive Surgical (ISRG) shares hit another record high Thursday, one day after the medical technology company issued preliminary fourth-quarter and full-year revenue above expectations amid growing demand for its surgical robotics equipment.
Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth
Intuitive Surgical (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
